Search Results - "Duran, Jason"

Refine Results
  1. 1

    Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides by Maisel, Alan S, Duran, Jason M, Wettersten, Nicholas

    Published in Heart failure clinics (01-01-2018)
    “…The natriuretic peptides play a vital role in normal physiology and as counter-regulatory hormones in heart failure (HF). Clinical assessment of their levels…”
    Get full text
    Journal Article
  2. 2

    Bone-Derived Stem Cells Repair the Heart After Myocardial Infarction Through Transdifferentiation and Paracrine Signaling Mechanisms by Duran, Jason M., Makarewich, Catherine A., Sharp, Thomas E., Starosta, Timothy, Zhu, Fang, Hoffman, Nicholas E., Chiba, Yumi, Madesh, Muniswamy, Berretta, Remus M., Kubo, Hajime, Houser, Steven R.

    Published in Circulation research (16-08-2013)
    “…RATIONALE:Autologous bone marrow–derived or cardiac-derived stem cell therapy for heart disease has demonstrated safety and efficacy in clinical trials, but…”
    Get full text
    Journal Article
  3. 3

    Mitochondria are secreted in extracellular vesicles when lysosomal function is impaired by Liang, Wenjing, Sagar, Shakti, Ravindran, Rishith, Najor, Rita H., Quiles, Justin M., Chi, Liguo, Diao, Rachel Y., Woodall, Benjamin P., Leon, Leonardo J., Zumaya, Erika, Duran, Jason, Cauvi, David M., De Maio, Antonio, Adler, Eric D., Gustafsson, Åsa B.

    Published in Nature communications (18-08-2023)
    “…Mitochondrial quality control is critical for cardiac homeostasis as these organelles are responsible for generating most of the energy needed to sustain…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Cardiovascular Manifestations of Mitochondrial Disease by Duran, Jason, Martinez, Armando, Adler, Eric

    Published in Biology (Basel, Switzerland) (11-05-2019)
    “…Genetic mitochondrial cardiomyopathies are uncommon causes of heart failure that may not be seen by most physicians. However, the prevalence of mitochondrial…”
    Get full text
    Journal Article
  7. 7

    Modeling Nonischemic Genetic Cardiomyopathies Using Induced Pluripotent Stem Cells by Khedro, Tarek, Duran, Jason M., Adler, Eric D.

    Published in Current cardiology reports (01-06-2022)
    “…Purpose of Review The advent of induced pluripotent stem cells (iPSC) has paved the way for new in vitro models of human cardiomyopathy. Herein, we will review…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Thin filament cardiomyopathies: A review of genetics, disease mechanisms, and emerging therapeutics by Keyt, Lucas K., Duran, Jason M., Bui, Quan M., Chen, Chao, Miyamoto, Michael I., Silva Enciso, Jorge, Tardiff, Jil C., Adler, Eric D.

    Published in Frontiers in cardiovascular medicine (07-09-2022)
    “…All muscle contraction occurs due to the cyclical interaction between sarcomeric thin and thick filament proteins within the myocyte. The thin filament…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Hyperphosphorylation of the Cardiac Ryanodine Receptor at Serine 2808 Is Not Involved in Cardiac Dysfunction After Myocardial Infarction by Zhang, Hongyu, Makarewich, Catherine A, Kubo, Hajime, Wang, Wei, Duran, Jason M, Li, Ying, Berretta, Remus M, Koch, Walter J, Chen, Xiongwen, Gao, Erhe, Valdivia, Héctor H, Houser, Steven R

    Published in Circulation research (16-03-2012)
    “…RATIONALE:Abnormal behavior of the cardiac ryanodine receptor (RyR2) has been linked to cardiac arrhythmias and heart failure (HF) after myocardial infarction…”
    Get full text
    Journal Article
  13. 13

    Sorafenib Cardiotoxicity Increases Mortality After Myocardial Infarction by Duran, Jason M, Makarewich, Catherine A, Trappanese, Danielle, Gross, Polina, Husain, Sharmeen, Dunn, Jonathan, Lal, Hind, Sharp, Thomas E, Starosta, Timothy, Vagnozzi, Ronald J, Berretta, Remus M, Barbe, Mary, Yu, Daohai, Gao, Erhe, Kubo, Hajime, Force, Thomas, Houser, Steven R

    Published in Circulation research (23-05-2014)
    “…RATIONALE:Sorafenib is an effective treatment for renal cell carcinoma, but recent clinical reports have documented its cardiotoxicity through an unknown…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Unique Features of Cortical Bone Stem Cells Associated With Repair of the Injured Heart by Mohsin, Sadia, Troupes, Constantine D, Starosta, Timothy, Sharp, Thomas E, Agra, Elorm J, Smith, Shavonn, Duran, Jason M, Zalavadia, Neil, Zhou, Yan, Kubo, Hajime, Berretta, Remus M, Houser, Steven R

    Published in Circulation research (04-12-2015)
    “…RATIONALE:Adoptive transfer of multiple stem cell types has only had modest effects on the structure and function of failing human hearts. Despite increasing…”
    Get full text
    Journal Article
  16. 16

    Low mortality in SARS‐CoV‐2 infected heart transplant recipients at a single center by Duran, Jason M., Barat, Masihullah, Lin, Andrew Y., King, Kevin R., Greenberg, Barry, Adler, Eric D., Aslam, Saima

    Published in Clinical transplantation (01-01-2022)
    “…Immunosuppressed heart transplant (HT) recipients are thought to be at higher risk of infection and mortality from SARS‐CoV‐2 infection coronavirus disease…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Mineralocorticoid receptor antagonist use following heart failure hospitalization by Duran, Jason M., Gad, Shady, Brann, Alison, Greenberg, Barry

    Published in ESC Heart Failure (01-04-2020)
    “…Aims Patients hospitalized for heart failure (HF) are at increased risk for events post‐discharge. Mineralocorticoid receptor antagonists (MRAs) improve the…”
    Get full text
    Journal Article
  19. 19
  20. 20